Conference
Development and Testing of a Lymphoma Clinical Trials Specific Frailty Index: A Secondary Analysis of the LY.12 Clinical Trial
Abstract
Abstract
Background: Frailty is common in older patients with lymphoma. However, it remains unknown whether frailty is prevalent in patients included in clinical trials of lymphoma, as those with frailty may meet inclusion criteria of a trial which do not include functional information beyond performance status (PS). Understanding the prevalence and impact of frailty in clinical trials is important to direct future …
Authors
Vijenthira A; Li X; Crump M; Hay AE; Shepherd LE; Meyer R; Djurfeldt MS; Chen BE; Prica A
Volume
138
Publisher
American Society of Hematology
Publication Date
November 5, 2021
DOI
10.1182/blood-2021-153037
Conference proceedings
Blood
Issue
Supplement 1
ISSN
0006-4971